Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Amortization of Deferred Charges (2019 - 2026)

Conmed filings provide 8 years of Amortization of Deferred Charges readings, the most recent being $1.3 million for Q1 2026.

  • On a quarterly basis, Amortization of Deferred Charges fell 11.57% to $1.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $5.5 million, a 4.48% decrease, with the full-year FY2025 number at $5.6 million, down 0.95% from a year prior.
  • Amortization of Deferred Charges hit $1.3 million in Q1 2026 for Conmed, up from -$36.7 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $50.1 million in Q4 2022 to a low of -$36.7 million in Q4 2025.
  • Median Amortization of Deferred Charges over the past 5 years was $1.4 million (2025), compared with a mean of $4.2 million.
  • The widest YoY moves for Amortization of Deferred Charges: up 837.3% in 2023, down 171.25% in 2023.
  • Conmed's Amortization of Deferred Charges stood at $50.1 million in 2022, then plummeted by 171.25% to -$35.7 million in 2023, then dropped by 0.22% to -$35.7 million in 2024, then dropped by 2.69% to -$36.7 million in 2025, then skyrocketed by 103.48% to $1.3 million in 2026.
  • The last three reported values for Amortization of Deferred Charges were $1.3 million (Q1 2026), -$36.7 million (Q4 2025), and $39.5 million (Q3 2025) per Business Quant data.